Viewing Study NCT05000450


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-27 @ 4:10 AM
Study NCT ID: NCT05000450
Status: TERMINATED
Last Update Posted: 2024-06-28
First Post: 2021-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Allogene Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module